Malin Corporation | MLC - Ordinary Share Capital


Malin Corporation reported EUR200K in Ordinary Share Capital for its fiscal semester ending in December of 2024.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
ALKERMES USD 166.46M 855K Mar/2026
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Eurofins Scientific SE EUR 177.9M 0 Dec/2025
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Lonza CHF 68.64M 0 Dec/2025
Malin Corporation EUR 200K 0 Dec/2024
Moderna USD 391M 2M Sep/2025
Organon & Co USD 260.32M 333K Dec/2025
Ovoca Bio EUR 29.49M 18.43M Jun/2025
Revvity USD 111.8M 1.57M Mar/2026
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
Viatris USD 1.16B 5.27M Mar/2026
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025